Bioxytran Inc. spotlighted a new scientific book by Dr. Avraham Mayevsky that introduces real-time physiological mapping techniques to monitor brain tissue oxygenation and metabolism. These methods, using FDA-cleared technology licensed to Bioxytran, could enhance evaluation of BXT-25, an investigational oxygen therapeutic designed to improve oxygen delivery in stroke and hypoxic conditions. The book details monitoring approaches for ischemia, hypoxia, and brain injuries, potentially aiding future research and development of oxygen therapies like BXT-25. Bioxytran continues to explore BXT-25’s applications in stroke and related disorders where oxygen delivery is impaired.
Bitcoin miners are experiencing declining revenue as the network's hash rate and mining difficulty fall, reflecting a shift of miners into AI infrastructure. Despite this stress, miners are accumulating Bitcoin, with reserves increasing by 1%, signal...
Lululemon invested in Syntetica's $30 million Series A funding to support its innovative recycling of Nylon 6 and Nylon 6,6, materials difficult to separate and reuse in textile waste. This move aligns with growing industry demand for sustainable, co...
Ethereum futures long positions among top traders increased by over 3 percentage points across both USDT- and coin-margined markets, indicating a broad-based shift in short-term sentiment. This rise suggests heightened attention on ETH compared to ot...
NVIDIA announced that leading Japanese companies in robotics and manufacturing are adopting its Cosmos, Isaac, Metropolis, and Jetson platforms to accelerate AI-powered intelligent machines across industries. The new Cosmos 3 Edge model enables real-...
Oil prices are rising sharply due to renewed US naval blockades on Iranian shipping and increased tensions in the Strait of Hormuz, a critical oil transit route. Brent crude is holding above $85 and WTI above $80, with forecasts suggesting WTI could ...
